h1

h2

h3

h4

h5
h6
% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@PHDTHESIS{Haverkamp:50462,
      author       = {Haverkamp, Lars Christian Arndt Simon},
      othercontributors = {Buse, Gerhard},
      title        = {{M}itochondriale {Z}ytopathien : {A}ufarbeitung der
                      unterschiedlichen {P}athogenese ausgewählter
                      mitochondrialer {Z}ytopathien anhand von zwei
                      {F}allbeispielen},
      address      = {Aachen},
      publisher    = {Publikationsserver der RWTH Aachen University},
      reportid     = {RWTH-CONV-113008},
      pages        = {98 S. : graph. Darst.},
      year         = {2008},
      note         = {Aachen, Techn. Hochsch., Diss., 2008},
      abstract     = {Mitochondrial cytopathies are a heterogeneous group of
                      diseases with a pathogenesis which is still not completely
                      understood. This paper shows the heterogeneity of
                      mitochondrial diseases on the basis of two clinical cases,
                      the problem of their clinical interpretation and the
                      unanswered questions concerning their pathogenesis.
                      Therefore the mitochondrial dna of the two patients is
                      analyzed by molecular genetic methods. The results are
                      discussed concerning the clinical, pathoanatomical and
                      molecular biological findings. Because of this approach a
                      special question is raised for each patient's special
                      findings. The first case is a patient suffering from LHON
                      with a lymphoma, who needed chemotherapy. Due to the
                      preliminary damaged mitochondria we were afraid of a higher
                      risk the therapy could cause, mainly because apoptosis is
                      discussed in the pathogenesis of LHON. In order to estimate
                      this risk the clinical diagnosis LHON has to be ensured by
                      molecular genetic examinations. The effects of the
                      chemotherapy were carefully clinically monitored and tested
                      in vitro. As a conclusion the influence of the detected
                      mutations on the cells' sensitivity for cytostatic drugs
                      should be evaluated. The second case shows
                      immunhistochemical signs of a Becker's muscular dystrophy,
                      but histological, electron microscopical and biochemical
                      signs for a mitochondrial myopathy. Damages in the
                      mitochondrial dna shall be found to explain the different
                      findings. Again the connection between the mitochondrial dna
                      alterations, the histological findings and the clinical
                      symptoms is of great importance. Finally an overview of the
                      assumed pathogenesis is given by literature research.},
      keywords     = {Mitochondrium (SWD) / Mitochondriale DNS (SWD) /
                      Optikusatrophie (SWD) / Mitochondriale Myopathie (SWD) /
                      Herzmuskelkrankheit (SWD) / Genmutation (SWD)},
      cin          = {513000-2},
      ddc          = {610},
      cid          = {$I:(DE-82)513000-2_20140620$},
      typ          = {PUB:(DE-HGF)11},
      urn          = {urn:nbn:de:hbz:82-opus-24717},
      url          = {https://publications.rwth-aachen.de/record/50462},
}